Risk of differentiation syndrome with enasidenib, warns US FDA

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1732卷 / 1期

关键词：

D O I：

10.1007/s40278-018-55460-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：4 / 4

相关论文

共 50 条

[31] FDA warns of MI, death risk with regadenoson, adenosine
[J]. Reactions Weekly, 2013, 1481 (1) : 3 - 3
[32] US FDA warns of high estrogen levels with Ortho Evra Patch
[J]. Reactions Weekly, 2005, 1078 (1) : 2 - 2
[33] Thyroiditis: A Rare Manifestation of Enasidenib-Induced Differentiation Syndrome
Annamaraju, Pavan
Gopishetty, Swathi
Goparaju, Naga
Beasey, Matthew
Kota, Vamsi
Guddati, Achuta K.
[J]. CASE REPORTS IN ONCOLOGY, 2020, 13 (02): : 583 - 587
[34] US FDA warns doctors to use cisapride as last resort only
Ault, A
[J]. LANCET, 1998, 352 (9122): : 120 - 120
[35] US FDA warns companies to stop distributing unapproved prescription narcotics
[J]. Reactions Weekly, 2009, 1247-1248 (1) : 3 - 3
[36] FDA warns antiepileptic drugs may increase risk of suicide
Ralat, Jose
[J]. CNS SPECTRUMS, 2008, 13 (03) : 191 - 191
[37] FDA warns of risk of eye infections with unapproved eye drops
[J]. Reactions Weekly, 2024, 1994 (1) : 3 - 3
[38] FDA warns about risk of botulinum toxin in dog food
不详
[J]. JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2007, 231 (05): : 684 - 684
[39] US FDA warns public about new butyrolactone-related agents
[J]. Reactions Weekly, 1999, 752 (1) : 3 - 3
[40] US FDA warns against the use of Liqiang 4 Dietary Supplement Capsules
[J]. Reactions Weekly, 2005, 1059 (1) : 2 - 2

← 1 2 3 4 5 →